According to six studies, plasma IGF-1 concentrations in patients with a mean BMI< 30 showed no major variations between patients in the OSAHS and control groups (SMD=-0.135, 95%CI= -2.73–0.23, P=0.46, Table 4). The gene discussed is IGF1; the disease is obstructive sleep apnea syndrome.